Mechanisms involved in enhancement of osteoclast formation by activin-A
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms involved in enhancement of osteoclast formation by activin-A
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 8, Pages 6974-6985
Publisher
Wiley
Online
2018-05-08
DOI
10.1002/jcb.26906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The immunoregulatory and fibrotic roles of activin A in allergic asthma
- (2015) C. L. Hardy et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Activin signalling and pre-eclampsia: From genetic risk to pre-symptomatic biomarker
- (2015) Rachel D. Williamson et al. CYTOKINE
- Genomewide Comprehensive Analysis Reveals Critical Cooperation Between Smad and c-Fos in RANKL-Induced Osteoclastogenesis
- (2015) Yasunori Omata et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures
- (2015) T. W. Fowler et al. JOURNAL OF CELL SCIENCE
- Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice
- (2015) Berno Dankbar et al. NATURE MEDICINE
- Neofunction of ACVR1 in fibrodysplasia ossificans progressiva
- (2015) Kyosuke Hino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ACVR1 R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A
- (2015) Sarah J. Hatsell et al. Science Translational Medicine
- The inhibin/activin signalling pathway in human gonadal and adrenal cancers
- (2014) Francesco Elia Marino et al. MOLECULAR HUMAN REPRODUCTION
- Follistatin, an Activin Antagonist, Ameliorates Renal Interstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
- (2014) Akito Maeshima et al. Biomed Research International
- Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma
- (2013) R Silbermann et al. LEUKEMIA
- Signaling by the TGF Superfamily
- (2013) J. L. Wrana Cold Spring Harbor Perspectives in Biology
- Osteoclast stimulatory transmembrane protein and dendritic cell-specific transmembrane protein cooperatively modulate cell-cell fusion to form osteoclasts and foreign body giant cells
- (2012) Hiroya Miyamoto et al. JOURNAL OF BONE AND MINERAL RESEARCH
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion
- (2012) A Sundqvist et al. ONCOGENE
- New insights into osteoclastogenic signaling mechanisms
- (2012) Tomoki Nakashima et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Value of serum and synovial fluid activin A and inhibin A in some rheumatic diseases
- (2010) Salwa S. EL-GENDI et al. International Journal of Rheumatic Diseases
- Bone remodeling and the osteoclast
- (2010) Steven L. Teitelbaum JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Is Not Essential for Osteoclast Activation
- (2010) Karen Fuller et al. PLoS One
- Local communication on and within bone controls bone remodeling
- (2009) Kim Henriksen et al. BONE
- Osteoclast lineage and function
- (2008) H. Kalervo Väänänen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
- (2008) Matthew C. Walsh et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started